Literature DB >> 27020445

Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study.

Fabio Fabbian1, Alfredo De Giorgi2, Fabio Manfredini3, Nicola Lamberti3, Silvia Forcellini4, Alda Storari4, Massimo Gallerani5, Gaetano Caramori6, Roberto Manfredini2.   

Abstract

BACKGROUND: We conducted a study, based on discharge hospital sheets [International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM)], in order to evaluate the relationship between chronic kidney disease (CKD), acute kidney injury (AKI), multi-morbidity, and in-hospital mortality (IHM).
METHODS: This study included all hospital admissions for chronic obstructive pulmonary disease (COPD) exacerbations between January 1, 2000, and December 31, 2013, recorded in the database of the University Hospital St. Anna of Ferrara. Age, sex, and diagnosis of CKD and AKI were collected, and Charlson comorbidity index (CCI) was calculated by ICD-9-CM codes. IHM was our main outcome.
RESULTS: We analyzed 7073 subjects with COPD exacerbation; they were more frequently male (56.9 vs 43.1 %), and mean age was 76.7 ± 9.8 years. Diagnosis of CKD was present in 771 patients (10.9 %), while AKI was diagnosed in 354 cases (5 %). A total of 554 patients (7.8 %) died during hospitalization, and LOS was 10.3 ± 11.2 days (median 8 days); the CCI corrected for CKD was 2.30 ± 1.65. Univariate analysis showed that IHM group had higher age (81.2 ± 7.9 vs 76.3 ± 9.9 years, p < 0.001), CCI (2.61 ± 2.21 vs 2.28 ± 1.62, p = 0.001), and LOS (11.1 ± 15.1 vs 10.3 ± 10.8 days, p = 0.001) and developed AKI more frequently (16.6 vs 4 %, p < 0.001) than survivors. Multivariate logistic regression analysis showed an independent association of IHM with age (OR 1.063; 95 % CI 1.050-1.075, p < 0.001), male sex (OR 1.229; 95 % CI 1.016-1.486, p = 0.033), logCCI (OR 2.051; 95 % CI 1.419-2.964, p < 0.001), and AKI (OR 3.849; 95 % CI 2.874-5.155, p < 0.001).
CONCLUSIONS: Acute kidney injury (AKI) represents a very important predictive factor of IHM in male older adult with multi-morbidity admitted because of COPD exacerbations.

Entities:  

Keywords:  Acute renal failure; Charlson comorbidity index; Chronic obstructive pulmonary disease; Chronic renal failure; ICD-9-CM; In-hospital mortality

Mesh:

Year:  2016        PMID: 27020445     DOI: 10.1007/s11255-016-1272-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  36 in total

Review 1.  COPD and its comorbidities: Impact, measurement and mechanisms.

Authors:  Netsanet A Negewo; Peter G Gibson; Vanessa M McDonald
Journal:  Respirology       Date:  2015-09-16       Impact factor: 6.424

2.  Clinical definition of COPD exacerbations and classification of their severity.

Authors:  Gaetano Caramori; Ian M Adcock; Alberto Papi
Journal:  South Med J       Date:  2009-03       Impact factor: 0.954

3.  Performance and limitations of administrative data in the identification of AKI.

Authors:  Morgan E Grams; Sushrut S Waikar; Blaithin MacMahon; Seamus Whelton; Shoshana H Ballew; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

4.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

5.  Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease.

Authors:  Wakae Hasegawa; Yasuhiro Yamauchi; Hideo Yasunaga; Mitsuhiro Sunohara; Taisuke Jo; Hiroki Matsui; Kiyohide Fushimi; Kazutaka Takami; Takahide Nagase
Journal:  BMC Pulm Med       Date:  2014-09-24       Impact factor: 3.317

6.  Diagnosis of acute kidney injury and its association with in-hospital mortality in patients with infective exacerbations of bronchiectasis: cohort study from a UK nationwide database.

Authors:  Masao Iwagami; Kathryn Mansfield; Jennifer Quint; Dorothea Nitsch; Laurie Tomlinson
Journal:  BMC Pulm Med       Date:  2016-01-19       Impact factor: 3.317

7.  Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD.

Authors:  Douglas W Mapel; Jenõ P Marton
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-03-15

8.  Chronic obstructive pulmonary disease: hospital and intensive care unit outcomes in the Kingdom of Saudi Arabia.

Authors:  Abdulsalam M Alaithan; Javed I Memon; Rifat S Rehmani; Arif A Qureshi; Abdul Salam
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-12-18

9.  Acute kidney injury in stable COPD and at exacerbation.

Authors:  M F Barakat; H I McDonald; T J Collier; L Smeeth; D Nitsch; J K Quint
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-28

Review 10.  COPD exacerbations: defining their cause and prevention.

Authors:  Jadwiga A Wedzicha; Terence A R Seemungal
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

View more
  16 in total

Review 1.  Is There an Association Between Chronic Obstructive Pulmonary Disease and Chronic Renal Failure?

Authors:  Nikolaos Madouros; Sommer Jarvis; Amber Saleem; Evgenia Koumadoraki; Shayka Sharif; Safeera Khan
Journal:  Cureus       Date:  2022-06-21

2.  Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy.

Authors:  Ugo Fedeli; Alfredo De Giorgi; Nicola Gennaro; Eliana Ferroni; Massimo Gallerani; Dimitri P Mikhailidis; Roberto Manfredini; Fabio Fabbian
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-27

3.  Impact of chronic kidney disease on mortality in older adults treated with pacemaker implantation.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Matteo Guarino; Michele Malagù; Matteo Bertini
Journal:  J Geriatr Cardiol       Date:  2017-10       Impact factor: 3.327

4.  Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.

Authors:  Jesús Recio Iglesias; Jesús Díez-Manglano; Francisco López García; José Antonio Díaz Peromingo; Pere Almagro; José Manuel Varela Aguilar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-07

5.  Validation and Comparison of a Modified Elixhauser Index for Predicting In-Hospital Mortality in Italian Internal Medicine Wards.

Authors:  Alfredo De Giorgi; Emanuele Di Simone; Rosaria Cappadona; Benedetta Boari; Caterina Savriè; Pablo J López-Soto; María A Rodríguez-Borrego; Massimo Gallerani; Roberto Manfredini; Fabio Fabbian
Journal:  Risk Manag Healthc Policy       Date:  2020-05-20

6.  Serum cystatin C: A potential predictor for hospital-acquired acute kidney injury in patients with acute exacerbation of COPD.

Authors:  Dawei Chen; Changchun Cao; Linglin Jiang; Yan Tan; Hongbo Yuan; Binbin Pan; Mengqing Ma; Hao Zhang; Xin Wan
Journal:  Chron Respir Dis       Date:  2020 Jan-Dec       Impact factor: 2.444

7.  The association between COPD and outcomes of patients with advanced chronic kidney disease.

Authors:  Chih-Cheng Lai; Che-Hsiung Wu; Ya-Hui Wang; Cheng-Yi Wang; Vin-Cent Wu; Likwang Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-17

8.  Infections and internal medicine patients: Could a comorbidity score predict in-hospital mortality?

Authors:  Fabio Fabbian; Alfredo De Giorgi; Benedetta Boari; Elisa Misurati; Massimo Gallerani; Rosaria Cappadona; Rosario Cultrera; Roberto Manfredini; Maria A Rodrìguez Borrego; Pablo J Lopez-Soto
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

Review 9.  Management of severe acute exacerbations of COPD: an updated narrative review.

Authors:  Ernesto Crisafulli; Enric Barbeta; Antonella Ielpo; Antoni Torres
Journal:  Multidiscip Respir Med       Date:  2018-10-02

10.  Community-acquired versus hospital-acquired acute kidney injury in patients with acute exacerbation of COPD requiring hospitalization in China.

Authors:  Chang-Chun Cao; Da-Wei Chen; Jing Li; Meng-Qing Ma; Yu-Bao Chen; Yi-Zhi Cao; Xi Hua; Wei Shao; Xin Wan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.